ImmunityBio, Inc. Profile Avatar - Palmy Investing

ImmunityBio, Inc.

ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulato…

Biotechnology
US, San Diego [HQ]
Value per Employee (VpE) · Surveys · Talents

Employees Analysis

Value per Employee (VpE)

No VpE graphs at the moment.

Employee Surveys

Employees Asked: -

No survey available at the moment.

Talent Acquisition

Permanent Employees

Last 12 Months:
Wage Range
Employees: -
Min.:$n/A
Avg.:$n/A
Max.:$n/A
Highest Demand Within Q3:

ImmunityBio, Inc. can't present the data

Top Demand Within Q3:

Not available for ImmunityBio, Inc.

Temporary Employees H1Bs

Last 12 Months:
Wage Range
Employees: -
Min.:$n/A
Avg.:$n/A
Max.:$n/A
Highest Demand Within Q3:

ImmunityBio, Inc. can't present the data

Top Demand Within Q3:

    Not available for ImmunityBio, Inc.

geographical
binding & acquisition

U.S. · Company Locations
Worldwide · Talent Acquisition
End of IBRX's Analysis
CIK: 1326110 CUSIP: 45256X103 ISIN: US45256X1037 LEI: - UEI: -
Secondary Listings
IBRX has no secondary listings inside our databases.